Xingang Pharmaceutical
Xingang Pharmaceutical Co., Ltd., commonly referred to as Xingang Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 2001, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, particularly in the fields of generic drugs and active pharmaceutical ingredients (APIs). With a strong operational presence across Asia and expanding into global markets, Xingang Pharma is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of medications that cater to various therapeutic areas, setting them apart through rigorous quality control and adherence to international standards. Xingang Pharma has achieved notable milestones, positioning itself as a trusted name in the industry, and continues to enhance its market presence through strategic partnerships and a focus on research and development.
DitchCarbon Score
How does Xingang Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Xingang Pharmaceutical's score of 15 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Xingang Pharmaceutical's reported carbon emissions
Xingang Pharmaceutical, headquartered in China (CN), currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not disclosed. Additionally, there are no documented reduction targets or climate pledges from the company, indicating a lack of formal commitments towards reducing carbon emissions or addressing climate change. In the context of the pharmaceutical industry, where sustainability is increasingly becoming a priority, the absence of such initiatives may reflect a need for improvement in environmental accountability. Overall, without specific emissions data or reduction commitments, it is challenging to assess Xingang Pharmaceutical's impact on climate change or their efforts towards sustainability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Xingang Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
